Dorrit T. Andersen
Conseiller Juridique Général chez Galecto Biotech ApS
Provenance du réseau au premier degré de Dorrit T. Andersen
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Galecto Biotech ApS
 Galecto Biotech ApS Pharmaceuticals: MajorHealth Technology Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark.
11
| Subsidiary | Pharmaceuticals: Major | 11 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Dorrit T. Andersen via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| PONIARD PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member | |
| COMPUGEN LTD. | Biotechnology | President | |
OrbiMed Capital LLC
 OrbiMed Capital LLC Financial ConglomeratesFinance Part of OrbiMed Advisors LLC, OrbiMed Capital LLC is a company based in New York, NY. | Financial Conglomerates | Private Equity Analyst | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
HBM Partners AG
 HBM Partners AG Investment ManagersFinance HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US. | Investment Managers | Private Equity Investor | |
| AEROCRINE AB | Electronic Equipment/Instruments | Founder | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Corporate Officer/Principal Chief Investment Officer | |
| The University of New Mexico | College/University | Corporate Officer/Principal | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Graduate Degree | |
| Technical University of Denmark | College/University | Undergraduate Degree Graduate Degree | |
AGC Biologics A/S
 AGC Biologics A/S Pharmaceuticals: MajorHealth Technology AGC Biologics A/S provides contract process development and biopharmaceuticals manufacturing services worldwide. It specializes in delivering custom solutions for the scale-up and the cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials, and commercial production. Its services include cell line development, bioprocess development, formulation, and analytical testing. The company was founded by Peter Vilby, Mads Laustsen, Thomas Sandal, and Morten Munk in 2001 and is headquartered in Soeborg, Denmark. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Southern Denmark | College/University | Undergraduate Degree Doctorate Degree | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Private Equity Investor | |
Biotech
 Biotech BiotechnologyHealth Technology The private company manufactures biotechnical products. The company is based in Cambridge, MA. | Biotechnology | Corporate Officer/Principal | |
| XYLO TECHNOLOGIES LTD | Medical Specialties | Director/Board Member | |
| SCISPARC LTD. | Pharmaceuticals: Major | Chief Executive Officer | |
RDD Pharma Ltd.
 RDD Pharma Ltd. Medical SpecialtiesHealth Technology RDD Pharma Ltd. develops pharmacological treatments for diseases of the anorectal region. The company was founded by Nir Barak in 2008 and is headquartered in Ramat Hachayal, Israel. | Medical Specialties | Director/Board Member | |
Dansk Biotek
 Dansk Biotek Miscellaneous Commercial ServicesCommercial Services Dansk Biotek is an industry association for biotech companies with promoting the biotechnological research, development and production in taking care of corporate interests in this regard, both nationally and internationally. The company was founded in 1987 and is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Novo Seeds
 Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark. | Investment Managers | Director of Investments Director of Investments | |
Otic Pharma Ltd.
 Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | Pharmaceuticals: Major | Chairman | |
| Life Cycle Pharma A/S | Corporate Officer/Principal | ||
Attgeno AB
 Attgeno AB Pharmaceuticals: MajorHealth Technology ATTGENO AB develops, manufactures, and trades pharmaceutical drugs and electronic apparatus. Its product, Supernitro, is a vasodilator indicated for the treatment of acute pulmonary hypertension associated with major cardiac surgery. The company is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chairman | |
| Compugen, Inc. (United States) | Corporate Officer/Principal | ||
| OBSEVA SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Medical Prognosis Institute, Inc. | Director/Board Member | ||
Nucleix Ltd.
 Nucleix Ltd. Medical/Nursing ServicesHealth Services Nucleix Ltd. develops, manufactures and markets non-invasive molecular cancer diagnostic tests. Its product Bladder EpiCheck is a urine test for monitoring of bladder cancer. The firm provides diagnostic tests for lung and colorectal cancer detection from blood samples, using its proprietary and highly innovative technology. The company was founded by Adam Wasserstrom, Dan Frumkin, and Elon A. Ganor in 2008 and is headquartered in Rehovot, Israel. | Medical/Nursing Services | Director/Board Member | |
Adicet Therapeutics, Inc.
 Adicet Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adicet Therapeutics, Inc. operates as a biopharmaceutical company focuses on the development of cell immunotherapies. It engages in the design and development of immunotherapies for cancer and other disease indications with a focus on novel universal immune cell therapies. The company was founded by Aya Jakobovits in 2014 and is headquartered in Beverly Hills, CA. | Pharmaceuticals: Major | Director/Board Member | |
FutuRx Ltd.
 FutuRx Ltd. Investment ManagersFinance FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona. | Investment Managers | Director/Board Member | |
| LOGICBIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
ReViral Ltd.
 ReViral Ltd. BiotechnologyHealth Technology ReViral Ltd. specializes in the areas of virology and antiviral therapies. It offers drugs to treat respiratory synctial virus infection. The company was founded by Neil Matthews and Stuart Cockerill in 2011 and is headquartered in Stevenage, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
IO Biotech ApS
 IO Biotech ApS BiotechnologyHealth Technology IO Biotech ApS operates as a clinical stage biotech company. It develops immunotherapy for cancer by targeting a mechanism used by tumour cells to evade immune responses. The company was founded by Mai-Britt Zocca, Mads Hald Andersen, Inge Marie Svane, Anders Ljungqvist and Per Thor Straten and is headquartered in Copenhagen, Denmark. | Biotechnology | Director/Board Member Chairman | |
Fore Biotherapeutics, Inc.
 Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Mordin AB | Corporate Officer/Principal | ||
| ELEDON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
BiomX Ltd.
 BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Pharmaceuticals: Major | Director/Board Member | |
Emendo Biotherapeutics, Inc.
 Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Emendo Biotherapeutics, Inc. engages in the development of genome editing technology. It specializes in protein engineering, molecular biology, and gene editing systems. The company was founded by David Baram, Lior Izhar, and Rachel Diamant in 2015 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
ADDI Medical AB
 ADDI Medical AB Packaged SoftwareTechnology Services ADDI Medical AB develops a communication platform for the healthcare industry. The private company is based in Stockholm, Sweden. | Packaged Software | Director/Board Member | |
| Addi Optioner AB | Director/Board Member | ||
| BIOMX INC. | Biotechnology | Director/Board Member | |
| GALECTO, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Chairman Director/Board Member Chief Operating Officer Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member | |
| Galecto Biotech AB | Chairman | ||
| Bioworks AB | Chairman | ||
Eir Ventures Partners AB
 Eir Ventures Partners AB Investment ManagersFinance Eir Ventures Partners AB (Eir Ventures) is an independent venture capital firm founded in 2020 by Dr Magnus Persson, Dr Stephan Christgau, Andreas Segerros and Dr Amanda Hayward. The firm is headquartered in Stockholm with an additional office in Copenhagen, Denmark. | Investment Managers | Chairman | |
River 2 Renal Corp.
 River 2 Renal Corp. Pharmaceuticals: MajorHealth Technology River 2 Renal Corp. develops novel therapies targeting orphan diseases in the renal space. The private company is based in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
Affinicon ApS
 Affinicon ApS Pharmaceuticals: MajorHealth Technology Affinicon ApS operates as a biotechnology company. It develops combinatory drugs for treatment of diseases such as inflammation, infections, and certain forms of cancer. The firm exploits a novel platform technology for targeted delivery of known drugs to macrophages. The company was founded by Niels Jonas Heilskov Graversen on July 4, 2013 and is headquartered in Aarhus, Denmark. | Pharmaceuticals: Major | Chairman Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 16 |
| Israël | 12 |
| Danemark | 12 |
| Suède | 10 |
| Suisse | 3 |
Sectorielle
| Health Technology | 29 |
| Finance | 8 |
| Consumer Services | 5 |
| Electronic Technology | 2 |
| Commercial Services | 2 |
Opérationnelle
| Director/Board Member | 189 |
| Corporate Officer/Principal | 38 |
| Independent Dir/Board Member | 35 |
| Chairman | 31 |
| Private Equity Investor | 16 |
Relations les plus connectées
| Insiders | |
|---|---|
| Gunnar Magnus Modee Persson | 51 |
| Søren Lemonius | 39 |
| Chau Khuong | 38 |
| Carl Goldfischer | 31 |
| Erez Chimovits | 30 |
| Nanna Liebach Lüneborg | 29 |
| Chandra Paul Leo | 22 |
| Søren Møller | 21 |
| Karen Wagner | 17 |
| Hans Schambye | 16 |
| Anders Pedersen | 10 |
- Bourse
- Insiders
- Dorrit T. Andersen
- Connexions Sociétés
